Immutep (ASX:IMM) - Key People
ASX:IMM · Directors, executives and key personnel · 12 month lookback
Mentioned in
Healthcare Wrap - Week 29 (13 July -> 17 July) 2026
18 July 2026
Immutep Reports Mature 30.9-Month Survival in 1L NSCLC but TACTI-004 Trial Halted
13 July 2026
Market Wrap - Week 16 (13 Apr -> 17 Apr) 2026
18 Apr 2026
Healthcare Wrap - Week 16 (13 Apr -> 17 Apr) 2026
18 Apr 2026
Also Mentioned
People named in Immutep (ASX:IMM) articles over the last 12 months, by frequency.
Frédéric Triebel
· 4 articles
Nuhad Ibrahim
· 4 articles
Marc Voigt, CEO of Immutep
· 3 articles
Eleanor Pearson, Sodali & Co.
· 3 articles
Matthew Beck, astr partners
· 3 articles
Reddy’s Laboratories SA
· 3 articles
med. Akin Atma
· 3 articles
Katarzyna Kozak, M.D.
· 3 articles
Paweł Sobczuk, M.D.
· 3 articles
Deanne Miller
· 2 articles
Marc Voigt - Chief Executive Officer and Chief Financial Officer
· 1 article
Russell Howard - Non-Executive Chairman
· 1 article
Frédéric Triebel - Executive Director and Chief Scientific Officer
· 1 article
Lis Boyce - Non-Executive Director
· 1 article
Deanne Miller - Chief Operating Officer, General Counsel and Company Secretary
· 1 article
Christian Mueller - Chief Development Officer
· 1 article
Stephan Winckels - Chief Medical Officer
· 1 article
Pete Meyers - former Non-Executive Director
· 1 article
Paweł Sobczuk
· 1 article
Chris Basta
· 1 article